aid: alector
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/alector.png
name: Alector
description: 'Alector is a clinical-stage biotechnology company developing immuno-neurology
  therapies for neurodegenerative diseases, including frontotemporal dementia (FTD),
  Alzheimer''s disease, and amyotrophic lateral sclerosis (ALS). Combining human genetics,
  neuroscience, and immunology, the company designs potential first- and best-in-class
  medicines that remove toxic proteins, replace deficient proteins, and restore immune
  and nerve cell function. Alector was added to the API Evangelist network as a GV
  portfolio company; it publishes no public developer API, SDK, or documentation surface,
  so this profile captures corporate and domain-security signals only.'
url: https://raw.githubusercontent.com/api-evangelist/alector/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Life Sciences
- Biotechnology
- Neuroscience
- Neurodegeneration
- Immunology
- Therapeutics
- Drug Development
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/alector-domain-security.yml
- type: Website
  url: http://alector.com
- type: PrivacyPolicy
  url: https://alector.com/privacy-policy/
- type: TermsOfService
  url: https://alector.com/terms-of-use-2/
- type: Support
  url: https://alector.com/contact/
- type: Blog
  url: https://investors.alector.com/news-events/news-releases
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence